Delivery Order SPE2DB20D2014-SPE2DB25FC75V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 mcg on June 17, 2025, with a ceiling value of $1,886.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 1,000 tablets of Synthroid 150 micrograms with a ceiling value of $1,575.33. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is due for ultimate completion on September 16, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 75 micrograms tablets in quantities of 1,000 units, with a contract ceiling value of $2,252.02. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 MCG tablets (1,000 count) on July 22, 2025, with a ceiling value of $1,090.43. The contract employs firm fixed price pricing and is scheduled for ultimate completion by July 23, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.37 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $50,535.07 delivery order on July 18, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. Performance will be completed by July 21, 2025, with fulfillment occurring at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 tablets of Synthroid 100 microgram at a ceiling value of $3,713.41. This non-competitive delivery order represents a firm fixed-price contract with an ultimate completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's existing...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC75VDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 micrograms on August 15, 2025, with a ceiling value of $1,430.59 and an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a wide range of medications and medical supplies to support military healthcare systems. The Synthroid order supports ongoing pharmaceutical needs across the Defense Health Agency and related federal healthcare operations, consistent with the company's extensive portfolio of brand-name and generic drug deliveries to defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/15/25 |